Accelerated hydroxychloroquine toxic retinopathy (response to letter)

被引：0
|
作者：
Ayushi Mohapatra
Prasad Gupta
Dhanashree Ratra
机构：
[1] Sankara Nethralaya,Department of Vitreoretinal Diseases
来源：
Documenta Ophthalmologica | 2024年 / 148卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：131 / 132
页数：1
相关论文
共 50 条
  • [41] Hydroxychloroquine retinopathy: screening and genetics
    F. H. Zaidi
    C. A. Rennie
    A. K. Drinkwater
    D. Sahu
    E. Akyol
    A. J. Lotery
    Eye, 2021, 35 : 1522 - 1523
  • [42] Hydroxychloroquine Induced Retinopathy in SLE
    Petri, Michelle
    Fu, Wei
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [43] HYDROXYCHLOROQUINE RETINOPATHY: IS SCREENING NECESSARY?
    Gobbett, Anne
    Smith, Jonathan
    Bracewel, Claire
    RHEUMATOLOGY, 2020, 59
  • [44] Hydroxychloroquine retinopathy: is screening necessary?
    Blyth, C
    Lane, C
    BRITISH MEDICAL JOURNAL, 1998, 316 (7133): : 716 - 717
  • [45] Hydroxychloroquine retinopathy in Korean patients
    Reactions Weekly, 2017, 1640 (1) : 7 - 7
  • [46] Hydroxychloroquine Whole Blood Levels Do Not Associate with Hydroxychloroquine Retinopathy
    Petri, Michelle
    Fu, Wei
    Shah, Syed Mahmood
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [47] Response to risk of hydroxychloroquine retinopathy is not related to systemic lupus erythematosus or rheumatoid arthritis
    Yesilirmak, Nilufer
    Telek, Hande Husniye
    Sungur, Gulten
    Ozdemir, Yaprak
    Yesil, Nesibe Karahan
    Ornek, Firdevs
    DOCUMENTA OPHTHALMOLOGICA, 2018, 136 (01) : 95 - 96
  • [48] Response to risk of hydroxychloroquine retinopathy is not related to systemic lupus erythematosus or rheumatoid arthritis
    Nilufer Yesilirmak
    Hande Husniye Telek
    Gulten Sungur
    Yaprak Ozdemir
    Nesibe Karahan Yesil
    Firdevs Ornek
    Documenta Ophthalmologica, 2018, 136 : 95 - 96
  • [49] Multimodal imaging characteristics of hydroxychloroquine retinopathy
    Saurabh, Kumar
    Roy, Rupak
    Thomas, Nicey Roy
    Chowdhury, Maitreyi
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2018, 66 (02) : 324 - 327
  • [50] Joint statement concerning retinopathy with hydroxychloroquine
    Reactions Weekly, 2021, 1846 (1) : 8 - 8
12345